Pegasys - pegasys.com : PEGASYS (peginterferon alfa-2a) Patient - Approved Treatment for Chronic Hepatitis C

3.22 Rating by ClearWebStats

pegasys.com is 2 decades 7 years 3 weeks old. This website has a #1,297,438 rank in global traffic. It has a .com as an domain extension. This website has a Google PageRank of 5 out of 10. This domain is estimated value of $ 480.00 and has a daily earning of $ 2.00. While no active threats were reported recently by users, pegasys.com is SAFE to browse.

Updated 9 years 11 months ago

Get Custom Widget

Traffic Report of Pegasys

Daily Unique Visitors:	371
Daily Pageviews:	742

Estimated Valuation

Income Per Day:	$ 2.00
Estimated Worth:	$ 480.00

Search Engine Indexes

Google Indexed Pages:	Not Applicable
Yahoo Indexed Pages:	Not Applicable
Bing Indexed Pages:	9

Search Engine Backlinks

Google Backlinks:	Not Applicable
Bing Backlinks:	15
Alexa BackLinks:	79

Safety Information

Google Safe Browsing:	No Risk Issues
Siteadvisor Rating:	No Risk Issues
WOT Trustworthiness:	Good
WOT Privacy:	Good
WOT Child Safety:	Not Applicable

Website Ranks & Scores

Google Pagerank:
Alexa Rank:	1,297,438
Domain Authority:	43 ON 100

Google Pagerank

PR 5 out of 10

PageSpeed Score

Siteadvisor Rating

No Risk Issues

Where is pegasys.com server located?

Hosted IP Address:

72.34.128.119

Hosted Country:

Location Latitude:

33.1959

Location Longitude:

-117.379

Social Engagement

Facebook Shares:	17
Facebook Likes:	Not Applicable
Facebook Comments:	Not Applicable
Twitter Count (Tweets):	Not Applicable
Linkedin Shares:	Not Applicable
Delicious Shares:	8

Page Resources Breakdown

Homepage Links Analysis

Page Title of Pegasys

PEGASYS (peginterferon alfa-2a) Patient - Approved Treatment for Chronic Hepatitis C

Meta Description of Pegasys

PEGASYS® (peginterferon alfa-2a) is a prescription medication that is: • used alone or with COPEGUS® (ribavirin, USP) to treat adults and children 5 years and older who have chronic (lasting a long time) hepatitis C infection and certain types of liver problems, and have not taken alpha interferon • used if you have chronic hepatitis C, you should not take PEGASYS by itself unless you are not able to take COPEGUS • used to treat adults with chronic hepatitis B virus who show signs that the virus is damaging the liver It is not known if PEGASYS is safe and will work in children under 5 years of age. PEGASYS, like other alpha interferons, may cause or worsen fatal or life-threatening problems (like mental, immune system, heart, liver, lung, intestinal and infections). Your doctor should monitor you during regular visits. If you show signs or symptoms of these conditions, your doctor may stop your medication. In many patients, but not all, these conditions get better after they stop taking PEGASYS (see the Medication Guide for more information and Warnings). Ribavirin, including COPEGUS®, can cause birth defects and/or death to an unborn baby. Female patients and the female partners of male patients should avoid getting pregnant. Ribavirin is known to cause anemia (low red blood cells), which can make heart disease worse (see the COPEGUS Medication Guide for more information and Warnings). What is the most important information I should know about PEGASYS? • COPEGUS in combination with PEGASYS may cause birth defects or death of your unborn baby. • PEGASYS therapy may cause you to develop mood or behavioral problems. • Some people who take PEGASYS alone or in combination with COPEGUS may get heart problems. • Stroke or symptoms of a stroke. • Some people taking PEGASYS develop new or worsening autoimmune problems. • Some people who take PEGASYS may get an infection. PEGASYS alone or in combination with COPEGUS can cause serious side effects. Some of these side effects may cause death. Tell your healthcare provider right away if you have any of these symptoms while taking PEGASYS. Do not take PEGASYS if you: • have certain other liver problems • have certain types of hepatitis caused by your immune system attacking your liver (autoimmune hepatitis) • have had a serious allergic reaction to another alpha interferon medicine or to any of the ingredients in PEGASYS. Do not take PEGASYS in combination with COPEGUS if you: • are pregnant, or planning to get pregnant during treatment or during the 6 months after treatment • are a male patient with a female sexual partner who is pregnant or plans to become pregnant at any time while you are being treated with COPEGUS or during the 6 months after your treatment has ended • have certain blood disorders such as thalassemia major or sickle-cell anemia • take didanosine (Videx® or Videx® EC) Do not give PEGASYS to a baby under 1 year of age. PEGASYS contains benzyl alcohol. Before taking PEGASYS, tell your healthcare provider about all your medical conditions or problems, and if you are pregnant or breastfeeding, or plan to become pregnant or breast feed during treatment with PEGASYS. Tell your healthcare provider about all the prescription and nonprescription medicines, vitamins and herbal supplements you take. PEGASYS can cause serious side effects including: blood problems, thyroid problems, blood sugar problems, serious eye problems, serious liver problems, worsening of liver problems including liver failure and death, lung problems, inflammation of your pancreas, inflammation of your intestines, serious allergic reactions and skin reactions, effect on growth in children, and nerve problems. The most common, but less serious, side effects of PEGASYS include: flu-like symptoms, tiredness and weakness, stomach problems, loss of appetite, skin reactions, hair thinning, trouble sleeping. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

Meta Tags of Pegasys

pegasys, pegassist, copegus, ribavirin, telaprevir, chronic hepatitis c, chronic hepatitis b, hepatitis virus, cirrhosis, liver, hepatitis c treatment

Website Inpage Analysis

H1 Headings:	Not Applicable	H2 Headings:	2
H3 Headings:	1	H4 Headings:	7
H5 Headings:	Not Applicable	H6 Headings:	Not Applicable
Total IFRAMEs:	Not Applicable	Total Images:	4
Google Adsense:	Not Applicable	Google Analytics:	UA-291924-42

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Fri, 23 May 2014 16:21:56 GMT
X-Powered-By: Servlet 2.5; JBoss-5.0/JBossWeb-2.1
Content-Disposition: inline;filename="index.html"
Accept-Ranges: bytes
ETag: /patient_1399392534449
Last-Modified: Tue, 06 May 2014 16:08:54 GMT
Content-Range: bytes 0-33439/33439
Content-Length: 33439
Keep-Alive: timeout=1, max=97
Connection: close
Content-Type: text/html;charset=UTF-8
Content-Language: en

Domain Information for pegasys.com

Domain Registrar:	SAFENAMES LTD
Registration Date:	1997-03-29 2 decades 7 years 3 weeks ago
Last Modified:	2013-12-23 1 decade 4 months 1 hour ago
Expiration Date:	2015-03-30 9 years 4 weeks 1 hour ago

Domain Nameserver Information

Host		IP Address	Country
hlrns1.roche.com		198.21.25.33	United States
ns1.roche.com		196.3.50.135	Switzerland

DNS Record Analysis

Host	Type	TTL	Extra
pegasys.com	A	3585	IP:72.34.128.119
pegasys.com	NS	3600	Target:ns1.roche.com
pegasys.com	NS	3600	Target:hlrns1.roche.com
pegasys.com	SOA	3600	MNAME:ns1.roche.com RNAME:global.hostmaster.roche.com Serial:2013061933 Refresh:10800 Retry:3600 Expire:604800
pegasys.com	TXT	3600	TXT:v=spf1 include:cmail1.com ip4:63.146.101.128/25 ~all